Attached files
| file | filename |
|---|---|
| 10-K - 10-K - ReShape Lifesciences Inc. | rsls-20191231x10k.htm |
| EX-10.32 - EX-10.32 - ReShape Lifesciences Inc. | rsls-20191231ex1032c5fd4.htm |
| EX-23.2 - EX-23.2 - ReShape Lifesciences Inc. | rsls-20191231ex23241deb8.htm |
| EX-21.1 - EX-21.1 - ReShape Lifesciences Inc. | rsls-20191231ex21130ffa2.htm |
| EX-4.1 - EX-4.1 - ReShape Lifesciences Inc. | rsls-20191231ex418f9e734.htm |
| EX-31.2 - EX-31.2 - ReShape Lifesciences Inc. | rsls-20191231ex312104178.htm |
| EX-10.33 - EX-10.33 - ReShape Lifesciences Inc. | rsls-20191231ex103348db2.htm |
| EX-10.31 - EX-10.31 - ReShape Lifesciences Inc. | rsls-20191231ex1031c7525.htm |
| EX-31.1 - EX-31.1 - ReShape Lifesciences Inc. | rsls-20191231ex311e739f0.htm |
| EX-32.2 - EX-32.2 - ReShape Lifesciences Inc. | rsls-20191231ex322f9e91d.htm |
| EX-32.1 - EX-32.1 - ReShape Lifesciences Inc. | rsls-20191231ex3214f43b2.htm |
| EX-10.34 - EX-10.34 - ReShape Lifesciences Inc. | rsls-20191231ex1034908c7.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ReShape Lifesciences Inc.
San Clemente, California
We hereby consent to the incorporation by reference in Registration Statements on Form S-8 (File Nos. 333-211940, 333-196646, 333-184181, 333-176174, 333-171244, 333-159592, and 333-149662), Form S-3 (File Nos. 333-216600, 333-205353, 333-195855, 333-183313, 333-171944, 333-170503, 333-171052, 333-166011, 333-158516, 333-224066, and 333-225083) and Form S-1 (Nos. 333-215590 and 333-213704), of ReShape Lifesciences Inc. of our report dated April 30, 2020, relating to the consolidated financial statements which appears in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP
Costa Mesa, California
|
|
|
|
|
/s/ BDO USA, LLP |
|
|
|
Costa Mesa, California |
|
|
|
April 30, 2020 |
|
|